EVAR and TEVAR: How Endovascular Repair Reshaped Aortic Treatment

Few areas of vascular medicine have changed as dramatically as aortic aneurysm treatment. Open surgical repair, once the only option, required large incisions, prolonged recovery, and carried substantial risk—particularly for older or frail patients. Endovascular repair, enabled by coated stent grafts, has transformed outcomes and expanded treatment to patients who previously had few options. This shift is central to the coated stent graft market's growth.

In the Coated Stent Graft Market, abdominal and thoracic aortic applications dominate. Endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms and thoracic endovascular aortic repair (TEVAR) for thoracic conditions have become standard approaches for anatomically suitable patients. Clinical trials and real-world data have demonstrated reduced perioperative mortality, shorter hospital stays, and faster recovery compared with open surgery.

Patient selection is important. Anatomy—including aneurysm location, shape, and access vessels—determines suitability. Imaging, particularly CT angiography, guides planning. Advanced stent graft designs, including fenestrated and branched devices, have expanded eligibility to patients with complex anatomy previously considered unsuitable for endovascular repair.

Long-term outcomes are an ongoing focus. While early benefits are clear, questions about long-term durability, reintervention rates, and surveillance requirements remain. Patients require lifelong imaging follow-up, and device design continues to evolve to improve long-term performance.

Geographically, adoption has been rapid in developed markets. Emerging markets are building endovascular programs, creating growth opportunities for device manufacturers and training providers. The competitive landscape includes major device companies and specialized developers.

Challenges include device costs, which can be substantial, and the need for specialized operator skills. Training and proctoring programs support adoption. Reimbursement varies by market.

Looking ahead, endovascular repair will likely expand further, driven by aging populations, technological advances, and evidence supporting outcomes. For manufacturers, success requires innovation, clinical evidence, and support for physician training. The shift from open to endovascular repair has been one of vascular surgery's defining transformations—and coated stent grafts are at its center.

People Also Ask

What is the difference between EVAR and TEVAR?
EVAR treats abdominal aortic aneurysms, while TEVAR treats thoracic aortic conditions—both use coated stent grafts delivered through minimally invasive techniques.

Is endovascular repair safer than open surgery?
For many patients, yes—EVAR and TEVAR offer lower perioperative risk, shorter recovery, and less trauma than open repair, though long-term follow-up is required.

Tags

#EVAR #TEVAR #AorticAneurysm #EndovascularSurgery #VascularHealth #StentGrafts